Source: Annual Congress 2004 - A translational approach to mechanisms of lung disease
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
L. R. S. Da Costa, E. R. Parra, V. L. Capelozzi (São Paulo, Brazil). Vascular activity and vessel density in idiophatic interstitial pineumonias. Eur Respir J 2004; 24: Suppl. 48, 2037

Member's Comments

No comment yet.

Related content which might interest you: Vascular density in fibrotic ILD: too much or not enough vessels? Source: Annual Congress 2012 - Pulmonary injury and repair from alveolus to vessel walls Year: 2012 Endothelial to mesenchymal transition: a precursor to post-COVID-19 interstitial pulmonary fibrosis and vascular obliteration? Source: Eur Respir J, 56 (4) 2003167; 10.1183/13993003.03167-2020 Year: 2020 Role of vascular endotelial growth factor polymorphisms in interstitial lung disease Source: International Congress 2019 – Novel methods, diagnostics and biomarkers in chronic lung diseases Year: 2019 Role of endothelial and smooth muscle cells in vascular wall remodeling of large pulmonary arteries in patients with CTEPH Source: Annual Congress 2007 - Venous thromboembolic disease Year: 2007 Pulmonary artery dilation and increased lung density in systemic sclerosis Source: International Congress 2015 – A more functional view of chest pathology Year: 2015 High expression of telomerase/endothelin-1 increase replication and activation of vascular myofibroblasts in usual interstitial pneumonia/idiopathic pulmonary fibrosis Source: Annual Congress 2010 - Pathogenesis of diffuse parenchymal lung disease Year: 2010 Pulmonary capillary hemangiomatosis (PCH): immunohistochemical analysis of vascular endothelial growth factor and its receptors Source: Annual Congress 2008 - Airway cell biology and immunology Year: 2008 Interstitial pressure and lung oedema in chronic hypoxia Source: Eur Respir J 2011; 37: 943-949 Year: 2011 Vascular endothelial growth factor (VEGF) and bronchial wall remodelling in asthma Source: Annual Congress 2004 - Genetics and molecular mechanisms of COPD and asthma Year: 2004 Vascular endothelial growth factor (VEGF) and airway inflammation in COPD. Correlation with pulmonary function Source: Eur Respir J 2006; 28: Suppl. 50, 653s Year: 2006 VEGF reduces pulmonary hypertension and vascular remodeling in pulmonary fibrosis through reduced endothelial apoptosis Source: Annual Congress 2009 - Pulmonary circulation I Year: 2009 Vascular remodeling process in usual interstitial pneumonia Source: Eur Respir J 2004; 24: Suppl. 48, 320s Year: 2004 Arterial stiffness and endothelial dysfunction in idiopathic pulmonary fibrosis (IPF) Source: Annual Congress 2011 - What is new in the approach to pulmonary fibrosis? Year: 2011 Pulmonary hypertension: the science behind the disease spectrum Source: Eur Respir Rev 2012; 21: 19-26 Year: 2012 Pulmonary artery diameter but not diameter ratio is indicative of pulmonary hypertension in systemic sclerosis Source: International Congress 2015 – A more functional view of chest pathology Year: 2015 Pulmonary vascular and cardiac impairment in interstitial lung disease Source: Eur Respir Rev 2017; 26: 160128 Year: 2017 Vascular smooth muscle cell phenotypes in primary pulmonary hypertension Source: Eur Respir J 2001; 17: 316-320 Year: 2001 LSC - 2018 - Pulmonary vascular remodeling mediated by ADORA2B in pulmonary artery smooth muscle cells Source: International Congress 2018 – Pathobiology of pulmonary hypertension Year: 2018 Vanishing vessels aboding pulmonary disease: a role for VEGFR2 Source: Eur Respir J, 55 (4) 2000326; 10.1183/13993003.00326-2020 Year: 2020